Journal Article

Unhealthy ageing: functional and socioeconomic impact

J. Avorn

in European Heart Journal Supplements

Published on behalf of European Society of Cardiology

Volume 3, issue suppl_N, pages N3-N5
Published in print November 2001 | ISSN: 1520-765X
Published online November 2001 | e-ISSN: 1554-2815 | DOI:
Unhealthy ageing: functional and socioeconomic impact

Show Summary Details


The long-term impacts of disease on functional status and on cost loom larger in the elderly than in any other age group. In older patients, the chronic sequelae of myocardial infarction and stroke often account for greater functional disability and resource utilization than does the initial acute presentation. In order to study this, quantitative measures from clinical and functional status assessments must be related to lifelong resource use. Rigorous measurement of such outcomes can render it possible to measure the impact on the health care system of specific cardiovascular and cerebrovascular consequences of ‘unhealthy ageing’. If performed in the context of a randomized clinical trial studying the effect of preventive measures, this approach can also lay the groundwork for assessment of the clinical and economic benefits of measures taken to reduce such morbidity.

Keywords: atherosclerosis; 3-hydroxy-3-methylglutaryl enzyme A (HMG-CoA) reductase inhibitors (statins); outcomes; pravastatin; Prospective Study of Pravastatin in the Elderly at Risk (PROSPER) study

Journal Article.  0 words. 

Subjects: Cardiovascular Medicine

Full text: subscription required

How to subscribe Recommend to my Librarian

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.